Delivery Order SPE2DB24D1201-SPE2DB24FJARV
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $12,452.74. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 4, 2025. The contract is not associated with a set-aside designation,...
This contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,127.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,287.37 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 4, 2024. The contract is not designated as a set-aside....
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $6,480.40 and is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with a ceiling value of $23,028.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a medication, with an ultimate completion date of September 27, 2024. This is a firm fixed price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,428.88, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 6, 2023. The award was made without any set-aside designation, indicating...
This federal contract award, valued at $7,824.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a completion date of December 18, 2023. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside requirement. Amerisourcebergen Drug Corp holds a significant...
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Delivery Order with a Firm Fixed Price valued at $2,574.74, with a completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a child of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $23,916.73 and an Ultimate Completion Date of May 31, 2022. It was awarded on May 27, 2022. There is no set-aside designation, indicating it was...
This federal contract award is a delivery order valued at $30,340.37 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4562646922 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price arrangement. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...